Allan R. Tenorio

4.2k citations

55 papers · 2.4k indexed · 3 hit papers · h-index 22

Virology top 0.5%
- HIV Research and Treatment 32
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 28
- HIV/AIDS Research and Interventions 18
Dermatology top 1%
- Dermatology and Skin Diseases 6
Immunology and Allergy top 2%
Emergency Medicine top 1%
Immunology
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 6
Hepatology
- Hepatitis C virus research 7
Physiology
- Asthma and respiratory diseases 5

Co-authors: Alan Landay Michael M. Lederman Ronald J. Bosch Benigno Rodríguez Steven G. Deeks Cara C. Wilson Arjun Seth Peter W. Hunt
Cited by: Virology Infectious Diseases Dermatology
Journals: JAIDS Journal of Acquired Immune Deficiency Syndromes (5 papers)The Journal of Infectious Diseases (4 papers)AIDS Research and Human Retroviruses (4 papers)
Partner nations: United States United Kingdom Spain

In The Last Decade

Allan R. Tenorio

52 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Allan R. Tenorio

Since Specialization

Citations

This map shows the geographic impact of Allan R. Tenorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan R. Tenorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan R. Tenorio more than expected).

Fields of papers citing papers by Allan R. Tenorio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan R. Tenorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan R. Tenorio. The network helps show where Allan R. Tenorio may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Allan R. Tenorio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Allan R. Tenorio Line = papers co-authored together Allan R. Tenorio links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rate Antiviral Research ·Susagna Argemí,Margaret Gartland,Jagadish Beloor,光昭久保田,Jana Wolf,Eugene L. Stewart,Andrew Clark,Allan R. Tenorio,Sandri Erfani	2024	0
2	Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study Frontiers in Immunology ·Josep M. Llibre,Judith A. Aberg,Sharon Walmsley,Juan D. Vélez,Carlos Zala,Brenda Crabtree‐Ramírez,Г.В. Кримець,양행용,Andrew Clark,Allan R. Tenorio,Amy Pierce,O Se-Min,Bo Li,Akihisa Shiraishi,D.D. Dung,Andreas Völkl	2024	1
3	Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study Open Forum Infectious Diseases ·Andrew Clark,Bisnupriya Sahu,D.D. Dung,Amy Pierce,José Castillo‐Mancilla,Akihisa Shiraishi,O Se-Min,Allan R. Tenorio	2024	1
4	Higher levels of response on clinical atopic dermatitis severity measures are associated with meaningful improvements in patient‐reported symptom and quality of life measures: Integrated analysis of three Upadacitinib phase 3 trials Journal of the European Academy of Dermatology and Venereology ·Kristian Reich,Marjolein de Bruin‐Weller,Mette Deleuran,Brian Calimlim,Yamagishi Ayana,Xiaofei Hu,Allan R. Tenorio,Jonathan I. Silverberg	2023	8
5	Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1 Infectious Diseases and Therapy ·Judith A. Aberg,Г.В. Кримець,Akihisa Shiraishi,Nicole A. Bechayda,Catharina Frank,Christine Katlama,Shannon Schrader,Joseph J. Eron,Princy Kumar,Eduardo Sprinz,Margaret Gartland,D.D. Dung,Andrew Clark,Amy Pierce,Max Lataillade,Allan R. Tenorio	2023	7
6	Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies Journal of Allergy and Clinical Immunology ·Emma Guttman‐Yassky,Jacob P. Thyssen,Jonathan I. Silverberg,Kim Papp,Amy S. Paller,Stephan Weidinger,Hwanhee Hong,Barbara A. Hendrickson,T. Degen,Allan R. Tenorio,Barry Ladizinski,Alvina D. Chu,John Liu,Alan D. Irvine	2022	43
7	Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min PLoS ONE ·Lisa Ross,A. Sarah Walker,Yu Lou,Allan R. Tenorio,Diana M. Gibb,M Mailys,Charles F. Gilks,Cynthia McCoig,Paula Munderi,Godfrey Musoro,Cissy Kityo,Heiner Grosskurth,James Hakim,Peter Mugyenyi,Amy Cutrell,Ji Yiru,Mark S. Shaefer	2019	2
8	Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery AIDS ·Anthony R. Cillo,Родина К. М.,Christina M. Lalama,John E. McKinnon,Robert W. Coombs,Allan R. Tenorio,Lawrence Fox,Rajesh T. Gandhi,Loïc Marchal,Judith S. Currier,Roy M. Gulick,Timothy Wilkin,John W. Mellors	2015	21
9	Short Communication: Apoptosis Pathways in HIV-1-Infected Patients Before and After Highly Active Antiretroviral Therapy: Relevance to Immune Recovery AIDS Research and Human Retroviruses ·David Pitrak,Richard Novák,Randee Estes,안종학,Cauê Conterno Barreira,Jeffrey Martinson,Holly N. Siegel,Allan R. Tenorio,Alan Landay	2014	8
10	Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy JAIDS Journal of Acquired Immune Deficiency Syndromes ·Benigno Rodríguez,David M. Asmuth,Roy M. Matining,John Spritzler,Jeffrey M. Jacobson,Robbie B. Mailliard,Xiao-Dong Li,Ana I. Martínez,Allan R. Tenorio,Franco Lori,Julianna Lisziewicz,K. De Bruyn,Charles R. Rinaldo,Richard B. Pollard	2013	46
11	HIV: So Near and Yet So Far Current HIV/AIDS Reports ·Allan R. Tenorio,Alan Landay	2012	4
12	A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4+ T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256 The Journal of Infectious Diseases ·Timothy Wilkin,Christina M. Lalama,J. Gregory McKinnon,Rajesh T. Gandhi,Nina Lin,Alan Landay,Heather J. Ribaudo,Lawrence K. Fox,Judith S. Currier,John W. Mellors,Roy M. Gulick,Allan R. Tenorio	2012	60
13	Treatment with Recombinant Growth Hormone Is Associated with Modest Improvement in CD4 Lymphocyte Reconstitution in HIV-Infected Persons on Antiretroviral Therapy: Results of ACTG A5174 AIDS Research and Human Retroviruses ·Kimberly Y. Smith,Lu Zheng,Ronald J. Bosch,David M. Margolis,Allan R. Tenorio,Laura A. Napolitano,Michael S. Saag,Elizabeth Connick,Barry H. Gross,Isaac R. Francis,Hernán Valdez,Norma Muurahainen,Pierre Maheu,Richard B. Pollard	2010	11
14	Delaying a Treatment Switch in Antiretroviral-Treated HIV Type 1-Infected Patients with Detectable Drug-Resistant Viremia Does Not Have a Profound Effect on Immune Parameters: AIDS Clinical Trials Group Study A5115 AIDS Research and Human Retroviruses ·Allan R. Tenorio,Hongyu Jiang,Yu Zheng,Barbara Bastow,Daniel R. Kuritzkes,John Bartlett,Steven G. Deeks,Alan Landay,Sharon A. Riddler	2009	2
15	Tratamiento de fractura del tercio medio facial mediante la técnica de midfacial deglobing: Reporte de un caso Revista Española de Cirugía Oral y Maxilofacial ·Allan R. Tenorio,Huaixing Kang	2008	0
16	The Relationship of T-Regulatory Cell Subsets to Disease Stage, Immune Activation, and Pathogen-Specific Immunity in HIV Infection JAIDS Journal of Acquired Immune Deficiency Syndromes ·Allan R. Tenorio,Jeffrey Martinson,S. A. Sergeyeva,Linda L. Baum,Alan Landay	2008	33
17	HIV Infection of Primary CD4 ⁺ Th2 Cells, Defined by Expression of The Chemoattractant Receptor-Homologous (CRTH2), Induces A Th0 Phenotype AIDS Research and Human Retroviruses ·崔英凯,Alan Landay,Allan R. Tenorio,Lena Al‐Harthi	2007	5
18	A Novel Bacterium Associated with Lymphadenitis in a Patient with Chronic Granulomatous Disease PLoS Pathogens ·David E. Greenberg,Li Ding,Adrian M. Zelazny,Frida Stock,M. S. T. Zulkarnain Tahmali,Victoria Anderson,Georgina Miller,David E. Kleiner,Allan R. Tenorio,Lauren Brinster,David W. Dorward,Patrick R. Murray,Steven M. Holland	2006	55
19	HIV-1–Infected Antiretroviral-Treated Patients With Prolonged Partial Viral Suppression JAIDS Journal of Acquired Immune Deficiency Syndromes ·Allan R. Tenorio,Kimberly Y. Smith,Daniel R. Kuritzkes,Beverly E. Sha,Betty A. Donoval,Russell K. Young,Cheryl Jennings,James W. Bremer,Susan Shott,Alan Landay,Harold A. Kessler	2003	22
20	Effectiveness of Gloves in the Prevention of Hand Carriage of Vancomycin-Resistant Enterococcus Species by Health Care Workers after Patient Care Clinical Infectious Diseases ·Allan R. Tenorio,Sheila Badri,Marjolein Van Daalen,Bala Hota,Marian Matushek,Mary K. Hayden,Gordon M. Trenholme,Robert A. Weinstein	2001	152

About Allan R. Tenorio

Allan R. Tenorio is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 55 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (28 papers), HIV/AIDS Research and Interventions (18 papers), Immune Cell Function and Interaction (8 papers), Hepatitis C virus research (7 papers), Dermatology and Skin Diseases (6 papers), T-cell and B-cell Immunology (6 papers) and Asthma and respiratory diseases (5 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.0k citations) and Dermatology (465 citations). Allan R. Tenorio has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Alan Landay, Michael M. Lederman, Ronald J. Bosch, Benigno Rodríguez, Steven G. Deeks, Cara C. Wilson, Arjun Seth, Peter W. Hunt, Supriya Krishnan and Jill Plants. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, The Journal of Infectious Diseases, AIDS Research and Human Retroviruses, Open Forum Infectious Diseases and Current HIV/AIDS Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact